Products from BPS Bioscience require a minimum order value above 400€
Encompassing Amino Acids: 31-254
Application: Useful for SDS-PAGE and pull-down assays.
Background: CD277 (cluster of differentiation 277), also known as BTN3A (butyrophilin subfamily 3), belongs to the BTN family of transmembrane receptors. CD277 is expressed in T and B cells, monocytes, dendritic cells, and NK cells. It can bind to pAGs (phosphate antigens), stimulating Vγ9Vδ2 T cells (gamma-delta T cells), a T cell type mainly found in the peripheral blood which can target cancer cells. It is also found in many cancer types and can be used as a prognosis marker in ovarian, breast, and bladder cancer, and in pancreatic ductal adenocarcinoma. Its expression levels vary with the type of cancer, with breast cancer showing lower levels, while advanced ovarian cancer can present high protein expression. A deeper understanding of the role of CD277 in each cancer type may open new targeted therapeutic opportunities.
Concentration: 0.64 mg/ml
Description: Recombinant human CD277 (cluster of differentiation 277), also known as BTN3A1, encompassing amino acids 31-254. This construct contains a C-terminal Avi-Tag™, followed by a His-Tag (6xHis). This protein was affinity purified.
Format: Aqueous buffer solution.
Formulation: 8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
Genbank: NM_007048.6
Host Cell Line: HEK293
Purity: ≥90%
Storage Stability: At least 6 months at -80°C.
Uniprot: O00481
Warnings: Avoid multiple freeze/thaw cycles.
Biosafety Level: Not applicable (BSL-1)
English
Deutsch
